| Financial Year |
March 31 2023 |
| Monetary Funds |
51,062,741.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
130,500.00 |
| Accounts Receivable |
424,283,889.54 |
| Advances to Suppliers |
25,518,799.71 |
| Other Receivables |
21,968,453.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
927,771,178.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,537,374.68 |
| Total Current Assets |
1,913,207,793.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
365,050,097.40 |
| Under-construction Projects |
2,866,555.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,494,321.71 |
| R&D expenses |
-- |
| Goodwill |
663,447,509.63 |
| Long-Term Deferred and Prepaid Expenses |
19,834,526.83 |
| Deferred Income Tax Assets |
153,956,438.69 |
| Other Non-Current Assets |
563,425,887.59 |
| Sub-Total of Non-Current Assets |
1,809,914,984.13 |
| Total Assets |
3,723,122,777.72 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
244,739,708.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,356,354.15 |
| Taxes Payable |
64,281,001.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
231,124,740.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,048,126,006.86 |
| Other Current Liabilities |
201,832.35 |
| Sub-Total of Current Liabilities |
1,720,339,926.17 |
| Long-term Loans |
34,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
244,520,208.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,747,204.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
307,203,859.67 |
| Total Liabilities |
2,027,543,785.84 |
| Paid-In Capital(Or Share Stock) |
465,032,880.00 |
| Capital Surplus |
336,113,702.39 |
| Surplus Reserve |
232,516,440.00 |
| LESS:Treasury Stock |
97,935,464.33 |
| Undistributed Profits |
748,070,124.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,695,578,991.88 |
| Owner's Equity（Stockholder's Equity） |
1,695,578,991.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,723,122,777.72 |
